Contract Research Firm R and G PharmaStudies Launches $175 Million Shenzhen IPO-- R and G PharmaStudies has launched its initial public offering on the Shenzhen Stock Exchange's ChiNext board, seeking to raise as much as 1.18 billion yuan . The Chinese contract research...